Early External Cephalic Version (ECV) 2 trial
- Conditions
- Pregnancies with a foetus in breech presentationPregnancy and Childbirth
- Registration Number
- ISRCTN56498577
- Lead Sponsor
- McMaster University Medical Centre (Canada)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 1460
1. Women with any breech presentation, aged 18 - 49 years old
2. A live singleton foetus
3. Gestational age of 33^0/7 - 35^6/7 weeks
1. Any contraindication to ECV
2. Previous participation in the EECV2 Trial
3. Any contraindication to early ECV
4. Women who wish a vaginal delivery if the foetus remains breech
5. Any contraindication to labour or vaginal birth
6. Women who wish to deliver by Caesarean Section (CS) if the foetus turns to cephalic
7. Women at increased risk of unstable lie
Please note that the following exclusion criteria was removed from this list on 06/11/2007:
8. Women who plan to move to a non-trial centre prior to delivery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of CS.<br><br>Outcomes will be measured at two planned interim analyses:<br>1. After 500 participants were recruited (analysis complete 02/2007)<br>2. After 900 participants were recruited (analysis expected to be complete 01/2008) <br>3. After the full sample of 1460 participants have been recruited
- Secondary Outcome Measures
Name Time Method 1. Rate of preterm birth<br>2. Other outcomes include admission to neonatal intensive care unit more than or equal to 24 hours, perinatal or neonatal mortality or serious neonatal morbidity, serious foetal complications, maternal death or serious maternal morbidity, non-cephalic presentation at birth, women's views, and health care costs<br><br>Outcomes will be measured at two planned interim analyses:<br>1. After 500 participants were recruited (analysis complete 02/2007)<br>2. After 900 participants were recruited (analysis expected to be complete 01/2008) <br>3. After the full sample of 1460 participants have been recruited